DHL adds six pharma brokers linking Europe, US to Asian hubs

DHL launched six new brokers that connect Europe and the United States with pharmaceutical hubs in Asia, covering routes such as Lieja‑Shanghai, Brussels‑Shanghai, Brussels‑Singapore, Cincinnati‑Singapore, Cincinnati‑Tokyo (Narita) and Cincinnati‑Seoul (Incheon).

The brokers give pharmaceutical customers greater routing flexibility, access to temperature‑controlled capacity and more predictable transit times, and the Brussels‑Cincinnati broker uses a dedicated 777F painted with the DHL Health Logistics livery. Priority countries include India, Singapore, Japan, South Korea, Brazil, the United States, Germany and Ireland; three Asian markets already have a broker while India and Brazil are pending. The rollout is part of a €2 billion plan for DHL Group’s life‑sciences and health business under its Strategy 2030.